Anti-TRIB3 antibody - Aminoterminal end,Abcam,AB50516

Host

Rabbit

Reactivity

Human

Application

WB

Platform ID

BAB938472519

Abcam

Headquarters

Discovery Drive Cambridge Biomedical Campus Cambridge CB2 0AX UK

Contact

Tel: +44 (0)1223 696000
Fax: +44 (0)1223 215 215

Product Specifications
Scientific Background

Specifications

NameAnti-TRIB3 antibody - Aminoterminal end
Cat. No.AB50516
HostRabbit
IsotypeIgG
ReactivityHuman
ApplicationWB
ClonalityPolyclonal
Concentration2.7 mg/mL Batch dependent concentration
ImmunogenSynthetic Peptide within Human TRIB3 aa 1-50 conjugated to Keyhole Limpet Haemocyanin. The exact immunogen used to generate this antibody is proprietary information.
PurityAffinity purification Immunogen
Appearance/FormLiquid
ShippingBlue Ice
FormulationpH: 7.4 Preservative: 0.097% Sodium azide Constituents: PBS
Storage-20°C
Regulatory StatusResearch Use Only

Scientific Background

Target data Inactive protein kinase which acts as a regulator of the integrated stress response (ISR), a process for adaptation to various stress (PubMed : 15775988, PubMed : 15781252). Inhibits the transcriptional activity of DDIT3/CHOP and is involved in DDIT3/CHOP-dependent cell death during ER stress (PubMed : 15775988, PubMed : 15781252). May play a role in programmed neuronal cell death but does not appear to affect non-neuronal cells (PubMed : 15775988, PubMed : 15781252). Acts as a negative feedback regulator of the ATF4-dependent transcription during the ISR : while TRIB3 expression is promoted by ATF4, TRIB3 protein interacts with ATF4 and inhibits ATF4 transcription activity (By similarity). Disrupts insulin signaling by binding directly to Akt kinases and blocking their activation (By similarity). May bind directly to and mask the 'Thr-308' phosphorylation site in AKT1 (By similarity). Interacts with the NF-kappa-B transactivator p65 RELA and inhibits its phosphorylation and thus its transcriptional activation activity (PubMed : 12736262). Interacts with MAPK kinases and regulates activation of MAP kinases (PubMed : 15299019). Can inhibit APOBEC3A editing of nuclear DNA (PubMed : 22977230). See full target information TRIB3

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.